Does Liminal BioSciences Inc (LMNL) Have What it Takes to be in Your Portfolio Monday?

Monday, April 10, 2023 01:13 PM | InvestorsObserver Analysts

Mentioned in this article

Does Liminal BioSciences Inc (LMNL) Have What it Takes to be in Your Portfolio Monday?

Liminal BioSciences Inc (LMNL) is near the bottom in its industry group according to InvestorsObserver. LMNL gets an overall rating of 0. That means it scores higher than 0 percent of stocks. Liminal BioSciences Inc gets a 0 rank in the Biotechnology industry. Biotechnology is number 38 out of 148 industries.

LMNL has an Overall Score of 0. Find out what this means to you and get the rest of the rankings on LMNL!

See Full LMNL Report

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in any industry with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Liminal BioSciences Inc Stock Today?

Liminal BioSciences Inc (LMNL) stock has gained 0.45% while the S&P 500 has fallen -0.12% as of 1:09 PM on Monday, Apr 10. LMNL has gained $0.03 from the previous closing price of $6.82 on volume of 102,418 shares. Over the past year the S&P 500 has fallen -7.08% while LMNL has fallen -23.80%. LMNL lost -$6.93 per share the over the last 12 months. Click Here to get the full Stock Report for Liminal BioSciences Inc stock.